Gamifant multiple strengths Images
Generic Name: emapalumab
This medication has been identified as Gamifant multiple strengths. It is supplied by Sobi Inc.
Gamifant is used in the treatment of Hemophagocytic Lymphohistiocytosis; Macrophage Activation Syndrome; Still's Disease and belongs to the drug class selective immunosuppressants. Gamifant multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Gamifant
- Generic Name
- emapalumab
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sobi Inc.
- National Drug Code (NDC)
- multiple
See also:
More about Gamifant (emapalumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.